Endocrine Cancer

ENDOCRINE CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Risk of Cancer-Specific Death May Remain Elevated for 30 Years

Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
PTSD in Cancer Patients: What Providers Need to Know

Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
Genomic Sequencing in Pediatric Cancer: For Every Patient at Every Relapse

More than one-third of tumors sequenced carried a high mutation burden.
How to Prevent a Cyberattack from Derailing Cancer Care

Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
Platinum Chemotherapy Appears to Cause Clonal Expansion Leading to Myeloid Neoplasms in Children With Neuroblastoma

Children treated for neuroblastoma developed myeloid neoplasms with specific platinum chemotherapy-associated mutation signatures.

ENDOCRINE CANCER NEWS

Multiple patients having chemotherapy in a room

Men Have Higher Risk of Cancer; Demographic and Lifestyle Factors Don’t Explain It

August 8, 2022

Thyroid Cancer Often Detected in Asymptomatic Patients

July 26, 2022

Blood type testing

Blood Type Linked to Outcomes of Immune Checkpoint Inhibitor Therapy in Metastatic Cancer

July 20, 2022

US Is Home to More Than 18 Million Cancer Survivors

June 30, 2022

Bridge Therapy Between Induction, ASCT May Slow Neuroblastoma

June 9, 2022

Next post in Endocrine Cancer

Bridge Therapy Between Induction, ASCT May Slow Neuroblastoma